IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $284,000 | -65.7% | 6,420 | -71.3% | 0.00% | -50.0% |
| Q2 2022 | $828,000 | -28.5% | 22,364 | -28.5% | 0.00% | 0.0% |
| Q1 2022 | $1,158,000 | +23.1% | 31,270 | +1.1% | 0.00% | +100.0% |
| Q4 2021 | $941,000 | -9.4% | 30,937 | -0.1% | 0.00% | -50.0% |
| Q3 2021 | $1,039,000 | +3.8% | 30,977 | +23.4% | 0.00% | 0.0% |
| Q2 2021 | $1,001,000 | +2.8% | 25,101 | +15.9% | 0.00% | 0.0% |
| Q1 2021 | $974,000 | +53.1% | 21,664 | +92.5% | 0.00% | +100.0% |
| Q4 2020 | $636,000 | +16.7% | 11,256 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $545,000 | -21.9% | 11,463 | -3.3% | 0.00% | -50.0% |
| Q2 2020 | $698,000 | +26.7% | 11,855 | +1.6% | 0.00% | +100.0% |
| Q1 2020 | $551,000 | -31.3% | 11,672 | -12.1% | 0.00% | -50.0% |
| Q4 2019 | $802,000 | – | 13,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |